Pfizer Set To Merge Generic Drug Business With Mylan

NEW YORK, NY - JULY 29: The Pfizer world headquarters stands in Midtown Manhattan on July 29, 2019 in New York City. On Monday morning, Pfizer announced the merger of its off-patent drug business with generic drugmaker Mylan. The new combined company will be based in the United States and Mylans EpiPen and Pfizers Viagra will be among its portfolio of products. (Photo by Drew Angerer/Getty Images)
NEW YORK, NY - JULY 29: The Pfizer world headquarters stands in Midtown Manhattan on July 29, 2019 in New York City. On Monday morning, Pfizer announced the merger of its off-patent drug business with generic drugmaker Mylan. The new combined company will be based in the United States and Mylans EpiPen and Pfizers Viagra will be among its portfolio of products. (Photo by Drew Angerer/Getty Images)
Pfizer Set To Merge Generic Drug Business With Mylan
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Canada (not Quebec). Restricted editorial rights for daily newspapers elsewhere, please call.
Credit:
Drew Angerer / Staff
Editorial #:
1158411792
Collection:
Getty Images News
Date created:
July 29, 2019
Upload date:
License type:
Release info:
Not released. More information
Source:
Getty Images North America
Object name:
775381928
Max file size:
5489 x 3659 px (18.30 x 12.20 in) - 300 dpi - 8 MB